Education
About Us
Working with TipRanks
Follow Us
Bausch Health Companies (BHC)
NYSE:BHC
Total Valuation
Bausch Health Companies has a market cap or net worth of $2.50B. The enterprise value is $31.91B.
Market Cap$2.50B
Enterprise Value$31.91B
Share Statistics
Bausch Health Companies has 370,516,940 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding370,516,940
Owned by Insiders20.23%
Owned by Institutions2.38%
Financial Efficiency
Bausch Health Companies’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is -2.96%.
Return on Equity (ROE)0.04
Return on Assets (ROA)>-0.01
Return on Invested Capital (ROIC)-2.96%
Return on Capital Employed (ROCE)0.08
Revenue Per Employee464.98K
Profits Per Employee-3.48K
Employee Count20,700
Asset Turnover0.36
Inventory Turnover1.74
Valuation Ratios
The current PE Ratio of Bausch Health Companies is 7.0. Bausch Health Companies’s PEG ratio is 0.70.
PE Ratio7.0
PS Ratio0.31
PB Ratio-2.32
Price to Fair Value-2.32
Price to FCF2.36
Price to Operating Cash Flow1.67
PEG Ratio0.70
Income Statement
In the last 12 months, Bausch Health Companies had revenue of 9.63B and earned -46.00M in profits. Earnings per share was -0.12.
Revenue9.63B
Gross Profit6.84B
Operating Income1.55B
Pretax Income167.00M
Net Income-46.00M
EBITDA2.82B
Earnings Per Share (EPS)-0.12
Cash Flow
In the last 12 months, operating cash flow was 1.51B and capital expenditures -402.00M, giving a free cash flow of 1.10B billion.
Operating Cash Flow1.51B
Free Cash Flow1.10B
Free Cash Flow per Share2.98
Dividends & Yields
Bausch Health Companies pays an annual dividend of $1, resulting in a dividend yield of ―
Dividend Per Share$1
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.81
52-Week Price Change-26.85%
50-Day Moving Average6.54
200-Day Moving Average6.26
Relative Strength Index (RSI)42.35
Average Volume (3m)1.58M
Important Dates
Bausch Health Companies upcoming earnings date is Feb 25, 2026, Before Open (Confirmed).
Last Earnings DateOct 29, 2025
Next Earnings DateFeb 25, 2026
Ex-Dividend DateNov 10, 2010
Financial Position
Bausch Health Companies as a current ratio of 0.86, with Debt / Equity ratio of -3720.62%
Current Ratio0.86
Quick Ratio0.62
Debt to Market Cap7.27
Net Debt to EBITDA7.24
Interest Coverage Ratio1.11
Taxes
In the past 12 months, Bausch Health Companies has paid 239.00M in taxes.
Income Tax239.00M
Effective Tax Rate1.43
Enterprise Valuation
Bausch Health Companies EV to EBITDA ratio is 8.29, with an EV/FCF ratio of 18.62.
EV to Sales2.43
EV to EBITDA8.29
EV to Free Cash Flow18.62
EV to Operating Cash Flow14.66
Balance Sheet
Bausch Health Companies has $1.73B in cash and marketable securities with $21.74B in debt, giving a net cash position of -$20.01B billion.
Cash & Marketable Securities$1.73B
Total Debt$21.74B
Net Cash-$20.01B
Net Cash Per Share-$54.01
Tangible Book Value Per Share-$46.09
Margins
Gross margin is 81.55%, with operating margin of 16.06%, and net profit margin of -0.48%.
Gross Margin81.55%
Operating Margin16.06%
Pretax Margin1.74%
Net Profit Margin-0.48%
EBITDA Margin29.32%
EBIT Margin16.16%
Analyst Forecast
The average price target for Bausch Health Companies is $8.33, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$8.33
Price Target Upside26.02% Upside
Analyst ConsensusHold
Analyst Count4
Revenue Growth Forecast―
EPS Growth Forecast―